NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
about
Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver DiseasePrimary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factorsEffect of dietary advanced glycation end products on mouse liverAn Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice.Evaluating the efficacy of Salsalate on prediabetic and diabetic patients with fatty liver: A randomized clinical trialPolyol accumulation in muscle and liver in a mouse model of type 2 diabetes.The relationship between hepatitis C virus infection and diabetes: time for a divorce?Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice.Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
P2860
Q26764843-C712D621-DA7D-4B44-9489-5953F1C5A28AQ30415672-D4C4C03C-842D-4C44-9FDC-002134613A7CQ34230496-F0756E91-3DA2-4799-9894-CABFB2E82F86Q36328050-85A9ABB7-B5BF-45E3-AF18-6DD0D82E024EQ36764962-6AAC3675-BAA3-40F8-B66A-26DDEED6A25DQ36872035-25950C8C-EF57-4607-B18E-E4805B8FE6B4Q39150702-FFF514CA-6E1E-4E5C-8356-7BE5BF941625Q39170768-11C5FBE7-DD67-4151-9CBB-3547E1D7E373Q41561798-301C09AE-F4F8-4A19-B9AA-42B34F8E3256Q42414753-E05304D7-4E19-4AFA-AF42-6BD8EB90B406Q43035632-B41821BB-DDCC-4FF2-8A30-5C1054547D21Q43240647-31EAC2DB-0A5D-4F5E-9557-7076EDB8A0C2Q51289305-987D16F0-0A38-4CE0-9C24-C28804732140Q53695403-2889CAEE-7C85-4F2C-BBB9-6408B0D8510E
P2860
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
@en
type
label
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
@en
prefLabel
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
@en
P1476
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
@en
P2093
Ester Vanni
Giulio Marchesini
P2888
P304
P356
10.1007/S11892-007-0029-Z
P577
2007-06-01T00:00:00Z